MedCity News March 3, 2022
The Series B financing round was co-led by Merck Global Health Innovation Fund and Amgen Ventures. The company’s Black female co-founders have prioritized overcoming systemic barriers to cancer prevention that have led to higher death rates for minorities.
CancerIQ announced Thursday that it has raised $14 million to grow its precision health platform focused on early cancer detection and prevention. The Chicago-based startup said the funding will also help the company strengthen and broaden its partnerships, including expanding its health system network, as it seeks to eliminate disparities in care.
The Series B financing round was co-led by Merck Global Health Innovation Fund and Amgen Ventures. McKesson Ventures, OSF Ventures — the investment arm of Peoria, Illinois-based OSF HealthCare and...
Today's Sponsors
Today's Sponsor